The Longterm Risk of Advanced Colorectal Neoplasia After Colonoscopy - A Population-based Cohort Study in Hong Kong

ConditionsColorectal Neoplasia Colorectal Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorChinese University of Hong Kong

About this trial

The primary objective of this study is to analyze the 15-year cumulative incidence of advanced colorectal neoplasia and CRC-related mortality after the index colonoscopy.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

We will identify patients from CDARS with colonoscopy performed from 1 January 2000 to 31 October 2020. Other relevant diagnoses, procedures, concomitant drugs, laboratory parameters and pathology results will be retrieved and studied.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

5,000 Participants

are grouped into 4 trial groups

Group A: Normal finding

Group B: Hyperplastic polyps

Group C: Low-risk adenomas

Group D: High-risk adenomas

Trial outcomes

Primary outcomes

Culumative incidence of advanced colorectal neoplasia

high-risk adenomas or CRC after 15 years of index conoloscopy

Time frame

15 years

Secondary outcomes

CRC-related mortality rate

the rate of mortality due to CRC-related incidents

Time frame

15 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chinese University of Hong Kong

Lead sponsor

Source ClinicalTrials.gov

Apply now